411 related articles for article (PubMed ID: 32009283)
1. The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.
Mahmud S; Mumtaz GR; Chemaitelly H; Al Kanaani Z; Kouyoumjian SP; Hermez JG; Abu-Raddad LJ
Addiction; 2020 Jul; 115(7):1244-1262. PubMed ID: 32009283
[TBL] [Abstract][Full Text] [Related]
2. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis.
Mumtaz GR; Weiss HA; Thomas SL; Riome S; Setayesh H; Riedner G; Semini I; Tawil O; Akala FA; Wilson D; Abu-Raddad LJ
PLoS Med; 2014 Jun; 11(6):e1001663. PubMed ID: 24937136
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions.
Harfouche M; Chemaitelly H; Kouyoumjian SP; Mahmud S; Chaabna K; Al-Kanaani Z; Abu-Raddad LJ
PLoS One; 2017; 12(10):e0187177. PubMed ID: 29088252
[TBL] [Abstract][Full Text] [Related]
4. Systematic overview of hepatitis C infection in the Middle East and North Africa.
Chaabna K; Cheema S; Abraham A; Alrouh H; Lowenfels AB; Maisonneuve P; Mamtani R
World J Gastroenterol; 2018 Jul; 24(27):3038-3054. PubMed ID: 30038471
[TBL] [Abstract][Full Text] [Related]
5. Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa.
Mumtaz GR; Weiss HA; Vickerman P; Larke N; Abu-Raddad LJ
AIDS; 2015 Aug; 29(13):1701-10. PubMed ID: 26372281
[TBL] [Abstract][Full Text] [Related]
6. Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis.
Heijnen M; Mumtaz GR; Abu-Raddad LJ
J Int AIDS Soc; 2016; 19(1):20873. PubMed ID: 27237131
[TBL] [Abstract][Full Text] [Related]
7. HIV incidence among people who inject drugs in the Middle East and North Africa: mathematical modelling analysis.
Mumtaz GR; Awad SF; Feizzadeh A; Weiss HA; Abu-Raddad LJ
J Int AIDS Soc; 2018 Mar; 21(3):e25102. PubMed ID: 29577623
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta-analyses, and meta-regressions.
Harfouche M; Chemaitelly H; Mahmud S; Chaabna K; Kouyoumjian SP; Al Kanaani Z; Abu-Raddad LJ
Epidemiol Infect; 2017 Nov; 145(15):3243-3263. PubMed ID: 28988562
[TBL] [Abstract][Full Text] [Related]
9. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S
Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus genotypes in the Middle East and North Africa: Distribution, diversity, and patterns.
Mahmud S; Al-Kanaani Z; Chemaitelly H; Chaabna K; Kouyoumjian SP; Abu-Raddad LJ
J Med Virol; 2018 Jan; 90(1):131-141. PubMed ID: 28842995
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.
Bao Y; Larney S; Peacock A; Colledge S; Grebely J; Hickman M; Degenhardt L; Leung J
Int J Drug Policy; 2019 Aug; 70():87-93. PubMed ID: 31125802
[TBL] [Abstract][Full Text] [Related]
12. Characterizing trends and associations for hepatitis C virus antibody prevalence in the Middle East and North Africa: meta-regression analyses.
Mahmud S; Chemaitelly H; Alaama AS; Hermez JG; Abu-Raddad LJ
Sci Rep; 2022 Nov; 12(1):20637. PubMed ID: 36450850
[TBL] [Abstract][Full Text] [Related]
13. Individual-level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesis.
Mahmud S; Kouyoumjian SP; Al Kanaani Z; Chemaitelly H; Abu-Raddad LJ
Ann Epidemiol; 2018 Jul; 28(7):452-461. PubMed ID: 29661680
[TBL] [Abstract][Full Text] [Related]
14. Key associations for hepatitis C virus genotypes in the Middle East and North Africa.
Mahmud S; Chemaitelly HS; Kouyoumjian SP; Al Kanaani Z; Abu-Raddad LJ
J Med Virol; 2020 Mar; 92(3):386-393. PubMed ID: 31663611
[TBL] [Abstract][Full Text] [Related]
15. A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?
Leung J; Peacock A; Colledge S; Grebely J; Cunningham EB; Hickman M; Vickerman P; Stone J; Trickey A; Dumchev K; Lynskey M; Hines L; Griffiths P; Mattick RP; Degenhardt L; Larney S
J Infect Dis; 2019 Jun; 220(1):78-90. PubMed ID: 30726973
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the hepatitis C virus epidemic in Pakistan.
Mahmud S; Al Kanaani Z; Abu-Raddad LJ
BMC Infect Dis; 2019 Sep; 19(1):809. PubMed ID: 31521121
[TBL] [Abstract][Full Text] [Related]
18. Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis.
Rajabi A; Sharafi H; Alavian SM
Harm Reduct J; 2021 Jan; 18(1):12. PubMed ID: 33482831
[TBL] [Abstract][Full Text] [Related]
19. Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.
Yuan JM; Croxford S; Viviani L; Emanuel E; Phipps E; Desai M
Int J Drug Policy; 2022 Nov; 109():103821. PubMed ID: 35994940
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of HIV/Hepatitis C Virus Co-Infection and Injection Risk Correlations in People Who Inject Drugs in Colombia: A Cross-Sectional Study Using Respondent Driven Sampling.
Toro-Tobón D; Berbesi-Fernández D
Subst Use Misuse; 2020; 55(3):414-423. PubMed ID: 31691646
[No Abstract] [Full Text] [Related]
[Next] [New Search]
